Huidan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huidan Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Jiayi Zhou
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, 250012, People’s Republic of China
2 shared publications- Linlin Cui
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China
2 shared publications - Han Zhao
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Clinical Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China
1 shared publication Hanbing Zhu
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University , Jinan, Shandong
1 shared publicationJing Li
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University , Jinan, Shandong
1 shared publicationLihong Xu
Department of Gynaecology and Obstetrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University , Jinan, Shandong
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 18, 1-14
Development and External Validation of Machine Learning Model to Predict Live Birth Following Assisted Reproductive Technology in Women with Ovarian Endometriomas: A Decision-Support Tool
Background: Ovarian endometriomas damage the ovarian structure, alter ovarian inflammation, and impair ovarian reserve. Given the conflicting results, determining an optimal reproductive strategy for women with endometriomas―whether expectant management, medication, surgery, or assisted reproductive technology (ART)―remains challenging. Objective: This study aims to preliminarily develop and validate clinically applicable decision-support tools by training, testing, and validating an automated machine learning (ML) model to predict the likelihood of live birth following ART in women with endometriomas. Methods: The derivation and testing cohort included 1705 women, and the external validation cohort included 1475 women with ovarian endometriomas following ART retrospectively. Two ML models were developed and validated to predict the probability of live birth. Model performance was evaluated using the area under the curve (AUC), accuracy, sensitivity, specificity, F1 score, and Brier score. The SHapley Additive exPlanations (SHAP) method was employed to interpret feature importance. Results: Comparing seven ML algorithms, the Extreme Gradient Boosting (XGBoost) demonstrated superior predictive performance both in model-1 and model-2, achieving an AUC of 0.90 [95% confidence interval (CI): 0.88– 0.92] and 0.88 (95% CI: 0.86– 0.89) in test-datasets and 0.80 (95% CI: 0.76– 0.83) and 0.69 (95% CI: 0.65– 0.73) in external validation cohort. The SHAP analysis revealed that the age and features associated with ovarian reserve had strong predictive power and the ovarian endometriomas had limited predictive power. Conclusion: Model-2, which uses only pre-ART variables, can support reproductive strategy selection prior to ART initiation. Conversely, Model-1 is designed to support embryo transfer strategy option after oocyte retrieval, incorporating post-ART data. Although both models show promise as decision-support tools for personalizing infertility treatment in women with endometriomas, their clinical implementation awaits confirmation from prospective, multicenter validation.
- 1 March 2026
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 18, 1-14
Open AccessDevelopment and External Validation of Machine Learning Model to Predict Live Birth Following Assisted Reproductive Technology in Women with Ovarian Endometriomas: A Decision-Support Tool
Background: Ovarian endometriomas damage the ovarian structure, alter ovarian inflammation, and impair ovarian reserve. Given the conflicting results, determining an optimal reproductive strategy for women with endometriomas―whether expectant management, medication, surgery, or assisted reproductive technology (ART)―remains challenging. Objective: This study aims to preliminarily develop and validate clinically applicable decision-support tools by training, testing, and validating an automated machine learning (ML) model to predict the likelihood of live birth following ART in women with endometriomas. Methods: The derivation and testing cohort included 1705 women, and the external validation cohort included 1475 women with ovarian endometriomas following ART retrospectively. Two ML models were developed and validated to predict the probability of live birth. Model performance was evaluated using the area under the curve (AUC), accuracy, sensitivity, specificity, F1 score, and Brier score. The SHapley Additive exPlanations (SHAP) method was employed to interpret feature importance. Results: Comparing seven ML algorithms, the Extreme Gradient Boosting (XGBoost) demonstrated superior predictive performance both in model-1 and model-2, achieving an AUC of 0.90 [95% confidence interval (CI): 0.88– 0.92] and 0.88 (95% CI: 0.86– 0.89) in test-datasets and 0.80 (95% CI: 0.76– 0.83) and 0.69 (95% CI: 0.65– 0.73) in external validation cohort. The SHAP analysis revealed that the age and features associated with ovarian reserve had strong predictive power and the ovarian endometriomas had limited predictive power. Conclusion: Model-2, which uses only pre-ART variables, can support reproductive strategy selection prior to ART initiation. Conversely, Model-1 is designed to support embryo transfer strategy option after oocyte retrieval, incorporating post-ART data. Although both models show promise as decision-support tools for personalizing infertility treatment in women with endometriomas, their clinical implementation awaits confirmation from prospective, multicenter validation.
- Open Access
- 7 March 2025
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2025 (2) , hoaf019
Effects of maternal poor ovarian response on the reproductive endocrine profiles of the next generation: a prospective cohort study in China
STUDY QUESTION: Do offspring born to mothers with poor ovarian response (POR) have alterations in their reproductive endocrine profile at 2–6 years of age compared to those born to mothers with normal ovarian response? SUMMARY ANSWER: Female offspring born to young mothers (<35 years) with expected POR were more likely to have low serum anti-Müllerian hormone (AMH) levels in childhood. WHAT IS KNOWN ALREADY: POR affects 32–43% of women in infertility clinics. Genetic susceptibility and potentially adverse intrauterine environments pose threats to the next generation. However, there is currently no direct evidence of intergenerational reproductive effects associated with POR. STUDY DESIGN, SIZE, DURATION: We conducted a prospective cohort study to investigate the intergenerational effects of maternal POR on reproductive endocrine health of offspring. Data were obtained from ‘Assisted Reproductive Technology-born KIDs (ARTKID)’, a birth cohort established in 2013 at a tertiary care center in China. A total of 3103 offspring, aged 2–6, born between 2013 and 2019, were recruited and included in our study until 2021. The exposed offspring conceived by ART were classified into four groups based on their mothers’ categorization using the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria. The unexposed offspring were born to mothers with normal ovarian response after ART. PARTICIPANTS/MATERIALS, SETTING, METHODS: Offspring conceived by ART provided blood samples at 2–6 years for the assessment of reproductive endocrine parameters. Mean difference and 95% CI were obtained based on a linear mixed model. The adjusted model accounted for paternal age, maternal age, offspring age, paternal smoking, use of ICSI, and frozen embryo transfer. MAIN RESULTS AND THE ROLE OF CHANCE: Female offspring born to young mothers with expected POR (POSEIDON Group 3) had lower AMH and PRL (prolactin) levels in childhood compared to controls (AMH: adjusted mean difference [AMD] = −0.64, 95% CI = −1.10, −0.18; PRL: AMD = −1.59, 95% CI = −2.97, −0.21). Female offspring born to older mothers (≥35 years) with expected POR (POSEIDON Group 4) showed a decreasing trend in AMH levels, though this difference was not statistically significant compared to controls [AMD = −0.60, 95% CI = −1.31, −0.12]. Female offspring born to young mothers with unexpected POR (POSEIDON Group 1) had lower DHEA-S (dehydroepiandrosterone sulfate) levels than controls [AMD = −1.38, 95% CI = −2.58, −0.17]. In contrast, male offspring born to POR mothers showed similar reproductive endocrine profiles as controls. LIMITATIONS, REASONS FOR CAUTION: The offspring were aged 2–6 years, limiting the ability to assess comprehensive reproductive phenotypic changes. Longer follow-up studies are necessary. WIDER IMPLICATIONS OF THE FINDINGS: The potential effects of maternal POR on reproductive endocrine profiles of offspring may be primarily linked to ovarian reserve. Genetic susceptibility, hypoandrogenism, and other intrauterine environmental factors may be probable explanations for reduction in AMH levels observed in female offspring born to young mothers with expected POR. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Key Research and Development Program of China (2022YFC2703000, 2022YFC2704404, 2024YFC2706902, 2022YFC2702905, 2024YFC2706700), CAMS Innovation Fund for Medical Sciences (2021-I2M-5-001), Shandong Provincial Natural Science Foundation (ZR2022JQ33), the Fundamental Research Funds of Shandong University (2023QNTD004), the National Special Support Program for High-level Talents, the Health Science and Technology Innovation Team Construction Project of Shandong Province, and the Taishan Scholars Program for Young Experts of Shandong Province (tsqn201909195). The authors declare that they have no competing interests. TRIAL REGISTRATION NUMBER: N/A.
- 7 March 2025
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2025 (2) , hoaf019
Open AccessEffects of maternal poor ovarian response on the reproductive endocrine profiles of the next generation: a prospective cohort study in China
STUDY QUESTION: Do offspring born to mothers with poor ovarian response (POR) have alterations in their reproductive endocrine profile at 2–6 years of age compared to those born to mothers with normal ovarian response? SUMMARY ANSWER: Female offspring born to young mothers (<35 years) with expected POR were more likely to have low serum anti-Müllerian hormone (AMH) levels in childhood. WHAT IS KNOWN ALREADY: POR affects 32–43% of women in infertility clinics. Genetic susceptibility and potentially adverse intrauterine environments pose threats to the next generation. However, there is currently no direct evidence of intergenerational reproductive effects associated with POR. STUDY DESIGN, SIZE, DURATION: We conducted a prospective cohort study to investigate the intergenerational effects of maternal POR on reproductive endocrine health of offspring. Data were obtained from ‘Assisted Reproductive Technology-born KIDs (ARTKID)’, a birth cohort established in 2013 at a tertiary care center in China. A total of 3103 offspring, aged 2–6, born between 2013 and 2019, were recruited and included in our study until 2021. The exposed offspring conceived by ART were classified into four groups based on their mothers’ categorization using the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria. The unexposed offspring were born to mothers with normal ovarian response after ART. PARTICIPANTS/MATERIALS, SETTING, METHODS: Offspring conceived by ART provided blood samples at 2–6 years for the assessment of reproductive endocrine parameters. Mean difference and 95% CI were obtained based on a linear mixed model. The adjusted model accounted for paternal age, maternal age, offspring age, paternal smoking, use of ICSI, and frozen embryo transfer. MAIN RESULTS AND THE ROLE OF CHANCE: Female offspring born to young mothers with expected POR (POSEIDON Group 3) had lower AMH and PRL (prolactin) levels in childhood compared to controls (AMH: adjusted mean difference [AMD] = −0.64, 95% CI = −1.10, −0.18; PRL: AMD = −1.59, 95% CI = −2.97, −0.21). Female offspring born to older mothers (≥35 years) with expected POR (POSEIDON Group 4) showed a decreasing trend in AMH levels, though this difference was not statistically significant compared to controls [AMD = −0.60, 95% CI = −1.31, −0.12]. Female offspring born to young mothers with unexpected POR (POSEIDON Group 1) had lower DHEA-S (dehydroepiandrosterone sulfate) levels than controls [AMD = −1.38, 95% CI = −2.58, −0.17]. In contrast, male offspring born to POR mothers showed similar reproductive endocrine profiles as controls. LIMITATIONS, REASONS FOR CAUTION: The offspring were aged 2–6 years, limiting the ability to assess comprehensive reproductive phenotypic changes. Longer follow-up studies are necessary. WIDER IMPLICATIONS OF THE FINDINGS: The potential effects of maternal POR on reproductive endocrine profiles of offspring may be primarily linked to ovarian reserve. Genetic susceptibility, hypoandrogenism, and other intrauterine environmental factors may be probable explanations for reduction in AMH levels observed in female offspring born to young mothers with expected POR. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Key Research and Development Program of China (2022YFC2703000, 2022YFC2704404, 2024YFC2706902, 2022YFC2702905, 2024YFC2706700), CAMS Innovation Fund for Medical Sciences (2021-I2M-5-001), Shandong Provincial Natural Science Foundation (ZR2022JQ33), the Fundamental Research Funds of Shandong University (2023QNTD004), the National Special Support Program for High-level Talents, the Health Science and Technology Innovation Team Construction Project of Shandong Province, and the Taishan Scholars Program for Young Experts of Shandong Province (tsqn201909195). The authors declare that they have no competing interests. TRIAL REGISTRATION NUMBER: N/A.